MODULATEURS DE CANAL CRAC POUR LE TRAITEMENT DU CANCER DE L'ƒ；SOPHAGE

• 收藏
• 分享

专利权人:

RHIZEN PHARMACEUTICALS SA

发明人:

VISWANADHA, SRIKANT,VAKKALANKA, SWAROOP KUMAR VENKATA SATYA

申请号：

CA3079141

公开号：

CA3079141A1

申请日:

2018.10.16

申请国别(地区):

CA

年份:

2019

代理人:

摘要：

The present invention relates to the use of a calcium release-activated calcium (CRAC) channel modulator, such as N-[4-(3,5-dicyclopropyl-1H-pyrazol-1-yl)phenyl]-2-(quinolin-6-yl)acetamide (Compound (A)) or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition containing such a CRAC channel modulator for the treatment of esophageal cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/